Is GHB listed under Schedule I of the Controlled Drugs and Substances Act?

GHB, or gamma-hydroxybutyrate, is indeed classified under Schedule I of the Controlled Drugs and Substances Act in Canada. This categorization indicates that GHB is recognized as a substance that poses significant potential for abuse, poses high risks of dependency, and lacks accepted medical use, barring certain specific contexts where it may be used legally (like in specialized medical treatments).

The inclusion of GHB in Schedule I means that its possession, trafficking, and production are strictly regulated and considered illegal without appropriate authorization. This classification is crucial for law enforcement and regulatory bodies to effectively combat the misuse of the substance, protect public health, and enforce the law surrounding controlled substances. Understanding this designation is important for individuals involved in law enforcement or those studying the legal aspects of controlled substances.